Related Experiment Video
Updated: Aug 6, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Contraindications to sentinel lymph node biopsy in cutaneous malignant melanoma
M S Lloyd1, A Topping, R Allan
1The Melanoma Unit, Department of Plastic and Reconstructive Surgery, St George's Healthcare NHS Trust, Blackshaw Road, Tooting, London SW17 OQT, UK. marksheldonlloyd@yahoo.co.uk
British Journal of Plastic Surgery
|November 17, 2004
Summary
This study reviews contraindications for sentinel node biopsy in cutaneous malignant melanoma. Findings are based on extensive data from our Melanoma Unit to guide clinical decisions.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Cutaneous malignant melanoma is a significant public health concern.
- Sentinel node biopsy is a key staging procedure for melanoma.
Purpose of the Study:
- To identify and discuss contraindications for sentinel node biopsy in melanoma patients.
- To provide evidence-based guidance for the appropriate use of this procedure.
Main Methods:
- Retrospective analysis of a large series of patients.
- Review of cases managed by a dedicated Melanoma Unit.
Main Results:
- Specific patient and tumor characteristics were identified as potential contraindications.
- The study highlights factors influencing the decision-making process for sentinel node biopsy.
Conclusions:
- Careful consideration of contraindications is essential for optimal patient selection for sentinel node biopsy.
- This analysis aims to refine surgical decision-making in melanoma management.
